StemCells (STEM) Provided Data on Phase I/II Trial in Spinal Cord Injury

May 19, 2014 8:10 AM

StemCells, Inc. (Nasdaq: STEM) announced today that Armin Curt, M.D., study principal investigator, presented an interim update on the Phase ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found